CIN85, a Cbl-interacting Protein, is a Component of AMAP1-mediated Breast Cancer Invasion Machinery

Overview

Journal EMBO J

Specialties Biotechnology
Molecular Biology

Date 2007 Jan 27

PMID 17255943

Citations 30

Authors

Jin-Min Nam

Yasuhito Onodera

Yuichi Mazaki

Hiroyuki Miyoshi

Shigeru Hashimoto

Hisataka Sabe

Affiliations

Soon will be listed here.

Abstract

Expression of AMAP1 correlates well with the invasive phenotypes and malignancy of human primary breast carcinomas. AMAP1 recruits its binding proteins, such as cortactin and paxillin, to sites of Arf6 activation to form invadopodia. A mouse ortholog of AMAP1, ASAP1, is known to bind to CIN85, a binding partner of an E3 ligase, Cbl. Here, we found that CIN85 colocalizes with AMAP1 at invadopodia, and binding of AMAP1 with CIN85 is important for the invasive activities of breast cancer cells, including MDA-MB-231. siRNA-mediated silencing of CIN85, as well as Cbl, also inhibited the invasion. We moreover found that AMAP1 is monoubiquitinated, rather than polyubiquitinated, by virtue of Cbl and provide evidence that the ability of AMAP1 to be monoubiquitinated is important for its involvement in invasion. Our results indicate that CIN85, as well as Cbl, which is a well-known suppressor of growth factor receptor signaling, can be positively involved in tumor invasion, and suggest that a complex epigenetic process is involved in AMAP1 function in breast cancer cell invasion.

Citing Articles

A computational framework for the inference of protein complex remodeling from whole-proteome measurements.

Buljan M, Banaei-Esfahani A, Blattmann P, Meier-Abt F, Shao W, Vitek O Nat Methods. 2023; 20(10):1523-1529.

PMID: 37749212 PMC: 10555833. DOI: 10.1038/s41592-023-02011-w.

E3 ligase-inactivation rewires CBL interactome to elicit oncogenesis by hijacking RTK-CBL-CIN85 axis.

Ahmed S, Buetow L, Gabrielsen M, Lilla S, Sibbet G, Sumpton D Oncogene. 2021; 40(12):2149-2164.

PMID: 33627783 PMC: 7994203. DOI: 10.1038/s41388-021-01684-x.

High expression of CIN85 promotes proliferation and invasion of human esophageal squamous cell carcinoma.

Hua X, Bie X, Cheng X, Zhang S Mol Med Rep. 2020; 23(1).

PMID: 33179079 PMC: 7673327. DOI: 10.3892/mmr.2020.11650.

Lysosomal trafficking mediated by Arl8b and BORC promotes invasion of cancer cells that survive radiation.

Wu P, Onodera Y, Giaccia A, Le Q, Shimizu S, Shirato H Commun Biol. 2020; 3(1):620.

PMID: 33110168 PMC: 7591908. DOI: 10.1038/s42003-020-01339-9.

A proximity-labeling proteomic approach to investigate invadopodia molecular landscape in breast cancer cells.

Thuault S, Mamelonet C, Salameh J, Ostacolo K, Chanez B, Salaun D Sci Rep. 2020; 10(1):6787.

PMID: 32321993 PMC: 7176661. DOI: 10.1038/s41598-020-63926-4.

References

Price J, Tiganis T, Agarwal A, Djakiew D, Thompson E . Epidermal growth factor promotes MDA-MB-231 breast cancer cell migration through a phosphatidylinositol 3'-kinase and phospholipase C-dependent mechanism. Cancer Res. 1999; 59(21):5475-8. View

Hall A, Jura N, DaSilva J, Jang Y, Gong D, Bar-Sagi D . hSpry2 is targeted to the ubiquitin-dependent proteasome pathway by c-Cbl. Curr Biol. 2003; 13(4):308-14. DOI: 10.1016/s0960-9822(03)00086-1. View

Take H, Watanabe S, Takeda K, Yu Z, Iwata N, Kajigaya S . Cloning and characterization of a novel adaptor protein, CIN85, that interacts with c-Cbl. Biochem Biophys Res Commun. 2000; 268(2):321-8. DOI: 10.1006/bbrc.2000.2147. View

Gout I, Middleton G, Adu J, Ninkina N, Drobot L, Filonenko V . Negative regulation of PI 3-kinase by Ruk, a novel adaptor protein. EMBO J. 2000; 19(15):4015-25. PMC: 306608. DOI: 10.1093/emboj/19.15.4015. View

Aaronson S . Growth factors and cancer. Science. 1991; 254(5035):1146-53. DOI: 10.1126/science.1659742. View

Thompson E, Paik S, Brunner N, Sommers C, Zugmaier G, Clarke R . Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J Cell Physiol. 1992; 150(3):534-44. DOI: 10.1002/jcp.1041500314. View

Coopman P, Thomas D, Gehlsen K, Mueller S . Integrin alpha 3 beta 1 participates in the phagocytosis of extracellular matrix molecules by human breast cancer cells. Mol Biol Cell. 1996; 7(11):1789-804. PMC: 276026. DOI: 10.1091/mbc.7.11.1789. View

Haglund K, Sigismund S, Polo S, Szymkiewicz I, Di Fiore P, Dikic I . Multiple monoubiquitination of RTKs is sufficient for their endocytosis and degradation. Nat Cell Biol. 2003; 5(5):461-6. DOI: 10.1038/ncb983. View

Friedl P, Wolf K . Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer. 2003; 3(5):362-74. DOI: 10.1038/nrc1075. View

10.

Ma X, Salunga R, Tuggle J, Gaudet J, Enright E, McQuary P . Gene expression profiles of human breast cancer progression. Proc Natl Acad Sci U S A. 2003; 100(10):5974-9. PMC: 156311. DOI: 10.1073/pnas.0931261100. View

11.

Di Fiore P, Polo S, Hofmann K . When ubiquitin meets ubiquitin receptors: a signalling connection. Nat Rev Mol Cell Biol. 2003; 4(6):491-7. DOI: 10.1038/nrm1124. View

12.

Jiang X, Sorkin A . Epidermal growth factor receptor internalization through clathrin-coated pits requires Cbl RING finger and proline-rich domains but not receptor polyubiquitylation. Traffic. 2003; 4(8):529-43. DOI: 10.1034/j.1600-0854.2003.t01-1-00109.x. View

13.

Kowanetz K, Szymkiewicz I, Haglund K, Kowanetz M, Husnjak K, Taylor J . Identification of a novel proline-arginine motif involved in CIN85-dependent clustering of Cbl and down-regulation of epidermal growth factor receptors. J Biol Chem. 2003; 278(41):39735-46. DOI: 10.1074/jbc.M304541200. View

14.

Haglund K, Di Fiore P, Dikic I . Distinct monoubiquitin signals in receptor endocytosis. Trends Biochem Sci. 2003; 28(11):598-603. DOI: 10.1016/j.tibs.2003.09.005. View

15.

Li M, Brooks C, Wu-Baer F, Chen D, Baer R, Gu W . Mono- versus polyubiquitination: differential control of p53 fate by Mdm2. Science. 2003; 302(5652):1972-5. DOI: 10.1126/science.1091362. View

16.

Hashimoto S, Onodera Y, Hashimoto A, Tanaka M, Hamaguchi M, Yamada A . Requirement for Arf6 in breast cancer invasive activities. Proc Natl Acad Sci U S A. 2004; 101(17):6647-52. PMC: 404099. DOI: 10.1073/pnas.0401753101. View

17.

Nakayama K, Frew I, Hagensen M, Skals M, Habelhah H, Bhoumik A . Siah2 regulates stability of prolyl-hydroxylases, controls HIF1alpha abundance, and modulates physiological responses to hypoxia. Cell. 2004; 117(7):941-52. DOI: 10.1016/j.cell.2004.06.001. View

18.

Kowanetz K, Husnjak K, Holler D, Kowanetz M, Soubeyran P, Hirsch D . CIN85 associates with multiple effectors controlling intracellular trafficking of epidermal growth factor receptors. Mol Biol Cell. 2004; 15(7):3155-66. PMC: 452573. DOI: 10.1091/mbc.e03-09-0683. View

19.

Tague S, Muralidharan V, DSouza-Schorey C . ADP-ribosylation factor 6 regulates tumor cell invasion through the activation of the MEK/ERK signaling pathway. Proc Natl Acad Sci U S A. 2004; 101(26):9671-6. PMC: 470733. DOI: 10.1073/pnas.0403531101. View

20.

Rizki A, Bissell M . Homeostasis in the breast: it takes a village. Cancer Cell. 2004; 6(1):1-2. DOI: 10.1016/j.ccr.2004.06.019. View